ANDA 76663, held by KV Pharmaceutical. Carbidopa; Levodopa.
As of Nov 21, 2026, ANDA 76663 (Carbidopa and Levodopa), held by KV Pharmaceutical, was first approved by FDA on Jun 24, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 24, 2004 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carbidopa and Levodopa50MG;200MG · tablet, extended release;oral | Carbidopa; Levodopa | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters